Literature DB >> 9504050

Vimentin: the conundrum of the intermediate filament gene family.

R M Evans1.   

Abstract

Intermediate filaments are a major component of the "cytoskeleton" of "higher" eukaryotes. These filaments are composed of a number of different, although structurally related, proteins. Different intermediate filament protein genes are expressed in different tissues. Spontaneous and experimentally produced mutations in the intermediate filament genes indicate that these filaments function to enhance the mechanical stability of epidermal and muscle cells. As a result, the use of transgenic mice with "knockout" or dominant negative mutations in IF genes has become an important approach for investigating the significance of IFs in other cell types. However, a knockout mutation of vimentin (-/-), the intermediate filament protein characteristically expressed in cells of mesenchymal origin, results in very subtle phenotypes that are not obviously related to cell fragility. Although experiments with cultured cells have described a variety of discrete changes in cell properties that are associated with vimentin expression or organization, there is no evidence yet that any of these properties are affected in the vimentin-/- mouse.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504050     DOI: 10.1002/(SICI)1521-1878(199801)20:1<79::AID-BIES11>3.0.CO;2-5

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  34 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

2.  Low-Level Laser Therapy Prevents Treadmill Exercise-Induced Progression of Arthrogenic Joint Contracture Via Attenuation of Inflammation and Fibrosis in Remobilized Rat Knees.

Authors:  Akinori Kaneguchi; Junya Ozawa; Kengo Minamimoto; Kaoru Yamaoka
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

3.  Ablation of vimentin results in defective steroidogenesis.

Authors:  Wen-Jun Shen; Syed Kashif Zaidi; Shailja Patel; Yuan Cortez; Masami Ueno; Rakia Azhar; Salman Azhar; Fredric B Kraemer
Journal:  Endocrinology       Date:  2012-04-24       Impact factor: 4.736

4.  Identification of a novel vimentin promoter and mRNA isoform.

Authors:  Zhangle Zhou; Søren Kahns; Anders Lade Nielsen
Journal:  Mol Biol Rep       Date:  2009-08-19       Impact factor: 2.316

Review 5.  Role of the cytoskeleton in formation and maintenance of angiogenic sprouts.

Authors:  Kayla J Bayless; Greg A Johnson
Journal:  J Vasc Res       Date:  2011-04-04       Impact factor: 1.934

6.  A novel role of vimentin filaments: binding and stabilization of collagen mRNAs.

Authors:  Azariyas A Challa; Branko Stefanovic
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

7.  The cytoskeleton meets the skeleton. Focus on "Deficiency of the intermediate filament synemin reduces bone mass in vivo".

Authors:  Omar Skalli
Journal:  Am J Physiol Cell Physiol       Date:  2016-10-26       Impact factor: 4.249

Review 8.  RNA protein interactions governing expression of the most abundant protein in human body, type I collagen.

Authors:  Branko Stefanovic
Journal:  Wiley Interdiscip Rev RNA       Date:  2013-05-28       Impact factor: 9.957

9.  The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature.

Authors:  Bin Xu; Robert M deWaal; Nirit Mor-Vaknin; Chris Hibbard; David M Markovitz; Mark L Kahn
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 10.  Myocardial fibroblast-matrix interactions and potential therapeutic targets.

Authors:  Edie C Goldsmith; Amy D Bradshaw; Michael R Zile; Francis G Spinale
Journal:  J Mol Cell Cardiol       Date:  2014-01-26       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.